Presidential Reception celebrating Female Entrepreneurship, Innovation, Creativity & Sustainable
DUBLIN, IRELAND – May 10, 2018 – Founder & Chief Scientific Officer of ATXA Therapeutics, Prof. Therese Kinsella, attended a reception...
Presidential Reception celebrating Female Entrepreneurship, Innovation, Creativity & Sustainable
ATXA Therapeutics to Attend the 2018 Medtech Strategist Innovation Summit
FDA Grants Orphan Drug Designation to ATXA’s NTP42 for the Treatment of PAH
ATXA Therapeutics receives EMA Orphan Drug Designation for NTP42 for the treatment of Pulmonary Arte
ATXA Therapeutics to Present at the 2018 Biotech and Money / Medtech and Money World Congress Showca